US-basedin vitrodiagnostic companyVenaxis, Inc. (NASDAQ: APPY) has entered into a series of agreements for a transaction with India's Strand Life Sciences Private Ltd. (Strand LS) and its shareholders, the company said.

Ballard Spahr LLP is acting as legal counsel to Venaxis.